What's driving the Self-Monitoring Blood Glucose Devices Market Growth? Top Players: Abbott, Ascensia Diabetes Care, ARKRAY,Inc., Nova Biomedical

The Self-Monitoring Blood Glucose Devices Market is set to exceed USD 20 billion by 2024; according to a new research report by Global Market Insights. Rising prevalence of diabetes worldwide is the key factor that will drive the self-monitoring blood glucose devices market during the forecast period. According to the Diabetes Atlas of International Diabetes Federation, in 2017, around 425 million people aged between 20-79 years globally, suffered from diabetes and is estimated to reach over 629 million by 2045. Diabetes is leading cause of death in many middle and low-income countries. Lifestyle changes, increased consumption of alcohol and tobacco along with other environmental factors will boost number of people suffering from diabetes.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2743

Technological innovations in self-monitoring blood glucose devices leading to development of portable, user-friendly and high efficiency self-monitoring blood glucose devices will boost the market growth over the analysis period. For instance, in 2015, Dexcom launched Dexcom G4 Platinum, consisting of an in-built hypoglycemia safety alert, customizable alerts to monitor rise and fall above user-selected limits as well as water-resistant sensor with attached transmitter. It works with Dexcom share app that sends real-time glucose values to the cloud allowing caregivers to monitor blood glucose readings. Increasing adoption of such technologically advanced self-monitoring blood glucose devices for diabetes management will upsurge the self-monitoring blood glucose devices market size throughout the forecast period.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Abbott
• Ascensia Diabetes Care
• ARKRAY,Inc.
• Nova Biomedical
• Bayer
• Dexcom
• Bayer Pharmaceuticals
• BKK B. Braun Melsungen AG
• BIONIME GmbH
• Essenlife Bioscience Inc.
• Medtronic
• Roche Diagnostics Europe
• Roche Diagnostics Middle East
• Sinocare Inc.

However, high maintenance cost of advanced blood glucose devices and their accessories may restrain the self-monitoring blood glucose devices market growth over the forecast period. Moreover, stringent regulations for manufacturing such blood glucose monitoring devices will impede the industry growth to certain extent. Testing strips segment dominated the self-monitoring blood glucose devices market in 2017 with more than 79.5% revenue share and is estimated to witness robust growth during the analysis period. Testing strips are an essential component of blood glucose meters that are widely used in diabetes care and management. Geriatric population base, prone to diabetes, will further increase the demand for SMBG devices.

Hospitals segment accounted for the highest revenue of USD 6.9 billion in 2017 and is estimated to witness lucrative CAGR of 4.6% during the forecast period. Increasing prevalence of diabetes across the world coupled with availability of technologically advanced blood glucose monitoring devices will serve to be high impact rendering factor in the segmental growth. Adoption of continuous glucose monitors for accurate, timely and efficient glucose measurement for ICU patients will stimulate the segmental growth in the coming years.

U.S. self-monitoring blood glucose devices market dominated global SMBG devices market with 34.2% revenue share in 2017 and is expected to show lucrative growth during the forecast period. Increasing prevalence of diabetes, availability of advanced healthcare infrastructure coupled with high healthcare expenditure are the key drivers that will accelerate industry growth over the coming years. Moreover, growing prevalence of obesity leading cause of diabetes will positively impact business growth. According to CDC, around 35.7% young adults aged between 20–39 years, 42.8% adults aged between 40-59 years, and 41.0% older population aged 60 and above suffered from obesity in 2016. Aforementioned factors will surge the U.S. self-monitoring blood glucose devices industry growth over the coming years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2743

Chapter 1. Methodology

1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary

2.1. Self-monitoring blood glucose devices industry 360º synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. End-user trends
2.1.4. Regional trends

Chapter 3. Self-Monitoring Blood Glucose Devices Industry Insights

3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024 (USD Billion)
3.3. Industry impact forces

3.3.1. Growth drivers
3.3.1.1. Rising prevalence of diabetes worldwide
3.3.1.2. Technological advancements in developed countries
3.3.1.3. Government initiatives for increasing awareness among people

3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of advanced devices and accessories in developing economies
3.3.2.2. Lack of reimbursement and stringent regulations for SMBG devices

Chapter 6. Self-Monitoring Blood Glucose Devices Market, By Region

6.1. Key regional trends

6.2. North America
6.2.1. Market size, by country, 2013 – 2024 (USD Million)
6.2.2. Market size, by product, 2013 – 2024 (USD Million)
6.2.3. Market size, by end-user, 2013 – 2024 (USD Million)

6.3. Europe
6.3.1. Market size, by country, 2013 – 2024 (USD Million)
6.3.2. Market size, by product, 2013 – 2024 (USD Million)
6.3.3. Market size, by end-user, 2013 – 2024 (USD Million)

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/self-monitoring-blood-glucose-devices-market

Data Tables

TABLE 1. Self-monitoring blood glucose devices industry 360° synopsis, 2013 – 2024
TABLE 2. Global self-monitoring blood glucose devices market, 2013 – 2024 (USD Billion)
TABLE 3. Global self-monitoring blood glucose devices market, by product, 2013 – 2024 (USD Million)
TABLE 4. Global self-monitoring blood glucose devices market, by end-user, 2013 – 2024 (USD Million)
TABLE 5. Global self-monitoring blood glucose devices market, by region, 2013 – 2024 (USD Million)

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.